The Puducherry facility, dedicated to Ibuprofen and its derivatives, is equipped with advanced infrastructure to serve both domestic and international markets
Chemicals delivered improved efficiency and optimal capacity utilization, with EBIT rising 37% YoY
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Agency initiates safety label change and notifies physicians of possible link
USFDA inspection at Emcure Pharmaceuticals API facility
SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024
The company recently received CEP certificate approval for Losartan Potassium by EDQM
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Subscribe To Our Newsletter & Stay Updated
